Mirum’s brelovitug meets primary endpoint in hepatitis delta trial

Lantheus doses first patient in prostate cancer imaging trial

Investing.com · News 9m ago

ALX Oncology reports trial data for gastric cancer drug

Investing.com · News 9m ago

Tempus AI receives FDA clearance for heart valve AI tool

Investing.com · News 9m ago

NeOnc schedules FDA meeting on brain cancer drug trial

Investing.com · News 9m ago

Allarity expands lab capabilities to support drug research

Investing.com · News 9m ago

Cantor Fitzgerald reiterates Neutral rating on Rivian stock at $19

Investing.com · News 10m ago

Cantor Fitzgerald reiterates Lucid stock rating on Saudi plant progress

Investing.com · News 11m ago

Brookline initiates Revolution Medicines stock with buy rating

Investing.com · News 11m ago

Cantor Fitzgerald reiterates Tesla stock rating on trucking outlook

Investing.com · News 11m ago

Cantor Fitzgerald reiterates Aurora Innovation stock Overweight rating

Investing.com · News 16m ago